MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management.
Minimed Group stock last closed at $17.64, down 0.17% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Health Information Services industry by N/A percentage points. Minimed Group stock is currently +65.63% from its 52-week low of $10.65, and -13.88% from its 52-week high of $20.48.
There are currently 280.84M shares of MMED outstanding. The market capitalization of MMED is $4.95B. In the past 24 hours, 1.76M MMED shares were traded.
How to Buy Minimed Group Stock
Not sure how to invest in Minimed Group stock? Here's how.
Decide where to buy Minimed Group stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you figure out where to buy Minimed Group stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Choose your method of payment and add your info.
Research Minimed Group stock: The Minimed Group ticker symbol is MMED. Is Minimed Group stock a good investment? Should you buy shares of MMED? How do MMED's underlying business fundamentals look? Do top analysts think Minimed Group is a good buy? Why has MMED's stock price moved recently? (Hint: Our stock research tools can help you figure out if MMED is a good stock to buy).
Execute your MMED buy order: Decide if you will purchase MMED shares at the current market price or use a limit order to purchase MMED shares at a given price.
Watch your MMED investment: Create a watchlist to key updates about your position in Minimed Group shares.
Step 1: Decide where to buy Minimed Group stock
You will need a brokerage account in order to access the NASDAQ market and buy MMED stock.
A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to world markets: From Tech to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal info so you can buy MMED stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Minimed Group stock
Once you have decided on the best place to buy Minimed Group stock, it's absolutely critical to evaluate their stock before you buy, so you actually comprehend the risk as well as the opportunity.
Minimed Group shares at a glance
MMED Price
$17.64
1w %
5.63%
1y %
N/A
5y %
N/A
P/E
-13.57x
P/B
1.37x
P/S
1.46x
PEG
N/A
Revenue
$3.10B
Earnings
-$333.00M
Fore. Rev. Growth
9.95%
Fore. Earn. Growth
N/A
Market Cap
$4.95B
Next Earnings
Sep 1, 2026
Next Dividend
N/A
Minimed Group Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis quickly.
There are more short-term assets than long-term liabilities on the MMED balance sheet.
MMED has a low debt to equity ratio of 0.28.
There are more short-term assets than short-term liabilities on the MMED balance sheet.
Failed Health Checks:
MMED has cash burn of 420000000. It does not have enough cash and short-term investments to cover this.
MMED has $298.00M in cash and short term investments. This is not sufficient to cover its annual cash burn of $420.00M.
MMED profit margin has gone down from -7.8% to -10.7% in the past year.
Is it a good time to buy Minimed Group stock, according to Wall Street analysts?
Out of 10 Equities analysts who give recommendations on MMED, the consensus analyst rating on Minimed Group is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest MMED Analyst Ratings
Joanne Wuensch, a top 9% analyst from Citigroup initiates coverage on MMED with a strong buy rating and announces their MMED price target of $23.00, on Mar 31, 2026.
Matthew O'Brien, a bottom 3% analyst from Piper Sandler initiates coverage on MMED with a hold rating and announces their MMED price target of $16.00, on Mar 31, 2026.
Anthony Petrone, a top 7% analyst from Mizuho initiates coverage on MMED with a buy rating and announces their MMED price target of $21.00, on Mar 31, 2026.
Kallum Titchmarsh, a bottom 13% analyst from Morgan Stanley initiates coverage on MMED with a strong buy rating and announces their MMED price target of $19.00, on Mar 31, 2026.
Daniel Markowitz, a top 40% analyst from Evercore ISI Group initiates coverage on MMED with a buy rating and announces their MMED price target of $20.00, on Mar 31, 2026.
Last year, MMED revenue was $3.10B. In the past three year, MMED's revenue has gone up by 72.54% per year. This was faster than the Health Information Services industry average of 27.87%.
No, Minimed Group doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your MMED buy order
You have two primary order types:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are mostly sufficient.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at an exact dollar amount limit, use a limit order.
Press the Open Trade button and eToro will execute the order.
If you need additional info about buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Minimed Group share?
As of Jul 28, 2026, it costs $17.64 to buy one share of Minimed Group stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.454 shares of MMED.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.